dexamethasone 21-phosphate has been researched along with Cystic Fibrosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bella, S; Lucidi, V; Tozzi, AE; Turchetta, A | 1 |
| Antonelli, A; Bianchi, M; Chiarantini, L; Crinelli, R; Fraternale, A; Magnani, M; Rossi, L | 1 |
1 trial(s) available for dexamethasone 21-phosphate and Cystic Fibrosis
| Article | Year |
|---|---|
A pilot trial on safety and efficacy of erythrocyte-mediated steroid treatment in CF patients.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Blood Transfusion, Autologous; Bronchopneumonia; Combined Modality Therapy; Cystic Fibrosis; Dexamethasone; Disease Susceptibility; Erythrocyte Membrane; Erythrocyte Transfusion; Female; Forced Expiratory Volume; Humans; Hypotonic Solutions; Male; Osmotic Fragility; Pilot Projects; Severity of Illness Index | 2006 |
1 other study(ies) available for dexamethasone 21-phosphate and Cystic Fibrosis
| Article | Year |
|---|---|
Erythrocyte-mediated delivery of drugs, peptides and modified oligonucleotides.
Topics: Cystic Fibrosis; Dexamethasone; Drug Delivery Systems; Erythrocytes; Genetic Therapy; Half-Life; Humans; Macrophages; Oligonucleotides; Pulmonary Disease, Chronic Obstructive; Recombinant Proteins | 2002 |